1. Home
  2. LFMDP vs RVPHW Comparison

LFMDP vs RVPHW Comparison

Compare LFMDP & RVPHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFMDP
  • RVPHW
  • Stock Information
  • Founded
  • LFMDP N/A
  • RVPHW 2018
  • Country
  • LFMDP United States
  • RVPHW United States
  • Employees
  • LFMDP 336
  • RVPHW 14
  • Industry
  • LFMDP Medical/Nursing Services
  • RVPHW Biotechnology: Pharmaceutical Preparations
  • Sector
  • LFMDP Health Care
  • RVPHW Health Care
  • Exchange
  • LFMDP Nasdaq
  • RVPHW Nasdaq
  • Market Cap
  • LFMDP N/A
  • RVPHW N/A
  • IPO Year
  • LFMDP N/A
  • RVPHW N/A
  • Fundamental
  • Price
  • LFMDP $23.65
  • RVPHW $0.06
  • Analyst Decision
  • LFMDP
  • RVPHW
  • Analyst Count
  • LFMDP 0
  • RVPHW 0
  • Target Price
  • LFMDP N/A
  • RVPHW N/A
  • AVG Volume (30 Days)
  • LFMDP N/A
  • RVPHW 22.4K
  • Earning Date
  • LFMDP N/A
  • RVPHW 03-14-2025
  • Dividend Yield
  • LFMDP N/A
  • RVPHW N/A
  • EPS Growth
  • LFMDP N/A
  • RVPHW N/A
  • EPS
  • LFMDP N/A
  • RVPHW N/A
  • Revenue
  • LFMDP N/A
  • RVPHW N/A
  • Revenue This Year
  • LFMDP N/A
  • RVPHW N/A
  • Revenue Next Year
  • LFMDP N/A
  • RVPHW N/A
  • P/E Ratio
  • LFMDP N/A
  • RVPHW N/A
  • Revenue Growth
  • LFMDP N/A
  • RVPHW N/A
  • 52 Week Low
  • LFMDP N/A
  • RVPHW $0.13
  • 52 Week High
  • LFMDP N/A
  • RVPHW $0.15
  • Technical
  • Relative Strength Index (RSI)
  • LFMDP 47.56
  • RVPHW N/A
  • Support Level
  • LFMDP $23.07
  • RVPHW N/A
  • Resistance Level
  • LFMDP $24.08
  • RVPHW N/A
  • Average True Range (ATR)
  • LFMDP 0.13
  • RVPHW 0.00
  • MACD
  • LFMDP -0.06
  • RVPHW 0.00
  • Stochastic Oscillator
  • LFMDP 48.86
  • RVPHW 0.00

About LFMDP LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

About RVPHW Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: